SPERO THERAPEUTICS INC

Ticker: SPRO CUSIP: 84833T103 Class: COM

Atlas Venture Life Science Advisors, LLC's Holding History (CIK: 0001917529)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 305,255 Value ($000) $220 Avg Close $0.84 Range $0.70 - $1.13
Q4 2024
Shares 305,255 Value ($000) $314 Avg Close $1.19 Range $0.92 - $1.36
Q3 2024
Shares 402,885 Value ($000) $540 Avg Close $1.34 Range $1.15 - $1.53
Q2 2024
Shares 535,336 Value ($000) $696 Avg Close $1.51 Range $1.25 - $1.81
Q1 2024
Shares 607,613 Value ($000) $1,045 Avg Close $1.57 Range $1.33 - $1.89
Q4 2023
Shares 1,013,438 Value ($000) $1,490 Avg Close $1.19 Range $0.99 - $1.50
Q3 2023
Shares 1,013,438 Value ($000) $1,226 Avg Close $1.39 Range $1.18 - $1.66
Q2 2023
Shares 1,013,438 Value ($000) $1,469 Avg Close $1.71 Range $1.39 - $2.00
Q1 2023
Shares 1,031,160 Value ($000) $1,495 Avg Close $1.67 Range $1.35 - $2.04
Q4 2022
Shares 1,031,160 Value ($000) $1,784 Avg Close $1.87 Range $1.46 - $2.28
Q3 2022
Shares 1,031,160 Value ($000) $2,062 Avg Close $0.99 Range $0.68 - $3.18
Q2 2022
Shares 1,031,160 Value ($000) $764 Avg Close $2.91 Range $0.73 - $7.87
Q1 2022
Shares 1,031,160 Value ($000) $8,971 Avg Close $10.25 Range $7.51 - $16.30
Q4 2021
Shares 1,031,160 Value ($000) $16,509 Avg Close $15.88 Range $12.64 - $18.84